Dr Matt Johnson joins’ Avacta’s R&D team

Avacta Group, a global provider of innovative diagnostic tools, consumables and reagents aimed at reducing the cost of human and animal healthcare, has announced that Dr Matt Johnson has joined Avacta to lead the Group’s Affimer technology development and production teams.  Dr Johnson joins Avacta from Abcam plc, one of the leading providers of research antibodies, where he was Head of R&D.